- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1746-6148
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Molecular alterations of the TLR4-signaling cascade in canine epilepsy ; volume:16 ; number:1 ; day:20 ; month:1 ; year:2020 ; pages:1-14 ; date:12.2020
BMC veterinary research ; 16, Heft 1 (20.1.2020), 1-14, 12.2020
- Urheber
-
Rüden, Eva-Lotta von
Gualtieri, Fabio
Schönhoff, Katharina
Reiber, Maria
Wolf, Fabio
Baumgärtner, Wolfgang
Hansmann, Florian
Tipold, Andrea
Potschka, Heidrun
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12917-020-2241-x
- URN
-
urn:nbn:de:101:1-2020042123014090749564
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
21.08.22500, 08:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rüden, Eva-Lotta von
- Gualtieri, Fabio
- Schönhoff, Katharina
- Reiber, Maria
- Wolf, Fabio
- Baumgärtner, Wolfgang
- Hansmann, Florian
- Tipold, Andrea
- Potschka, Heidrun
- SpringerLink (Online service)
Ähnliche Objekte (12)
Treatment in canine epilepsy – a systematic review
”Search for biomarkers and pathogenesis studies in canine epilepsy”
Pharmacomicrobiomics in canine idiopathic epilepsy and its behavioral comorbidities
International Veterinary Epilepsy Task Force consensus proposal: medical treatment of canine epilepsy in Europe
ADAM23 is a common risk gene for canine idiopathic epilepsy
International veterinary epilepsy task force consensus proposal: outcome of therapeutic interventions in canine and feline epilepsy
Lipopolysaccharide mediates immuno-pathological alterations in young chicken liver through TLR4 signaling
Chemoarchitectural signatures of subcortical shape alterations in generalized epilepsy
Assessment into the usage of levetiracetam in a canine epilepsy clinic
Re-evaluating the placebo response in recent canine dietary epilepsy trials
Hippocampal expression of the cannabinoid receptor type 1 in canine epilepsy
TLR4-dependent neuroinflammation mediates LPS-driven food-reward alterations during high-fat exposure
Treatment in canine epilepsy – a systematic review
”Search for biomarkers and pathogenesis studies in canine epilepsy”
Pharmacomicrobiomics in canine idiopathic epilepsy and its behavioral comorbidities
International Veterinary Epilepsy Task Force consensus proposal: medical treatment of canine epilepsy in Europe
ADAM23 is a common risk gene for canine idiopathic epilepsy
International veterinary epilepsy task force consensus proposal: outcome of therapeutic interventions in canine and feline epilepsy
Lipopolysaccharide mediates immuno-pathological alterations in young chicken liver through TLR4 signaling
Chemoarchitectural signatures of subcortical shape alterations in generalized epilepsy
Assessment into the usage of levetiracetam in a canine epilepsy clinic
Re-evaluating the placebo response in recent canine dietary epilepsy trials
Hippocampal expression of the cannabinoid receptor type 1 in canine epilepsy
TLR4-dependent neuroinflammation mediates LPS-driven food-reward alterations during high-fat exposure
Treatment in canine epilepsy – a systematic review
”Search for biomarkers and pathogenesis studies in canine epilepsy”
Pharmacomicrobiomics in canine idiopathic epilepsy and its behavioral comorbidities
International Veterinary Epilepsy Task Force consensus proposal: medical treatment of canine epilepsy in Europe
ADAM23 is a common risk gene for canine idiopathic epilepsy
International veterinary epilepsy task force consensus proposal: outcome of therapeutic interventions in canine and feline epilepsy
Lipopolysaccharide mediates immuno-pathological alterations in young chicken liver through TLR4 signaling
Chemoarchitectural signatures of subcortical shape alterations in generalized epilepsy
Assessment into the usage of levetiracetam in a canine epilepsy clinic
Re-evaluating the placebo response in recent canine dietary epilepsy trials
Hippocampal expression of the cannabinoid receptor type 1 in canine epilepsy